Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The GREPONET Study
Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Franca R, Scaefer N, Sundin A, Pavel ME, Dromain C (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 106
Pages Range: 178-178
Authors with CRIS profile
Involved external institutions
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
Switzerland (CH)
Uppsala University Hospital / Akademiska sjukhuset
Sweden (SE)
Beaujon Hospital / Hôpital Beaujon
France (FR)
Hospital Israelita Albert Einstein
Brazil (BR)
The University Hospital in Krakow
Poland (PL)
Hospital Sírio-Libanês
Brazil (BR)
Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV)
Spain (ES)
Christie NHS Foundation Trust
United Kingdom (GB)
Switzerland (CH)
Uppsala University Hospital / Akademiska sjukhuset
Sweden (SE)
Beaujon Hospital / Hôpital Beaujon
France (FR)
Hospital Israelita Albert Einstein
Brazil (BR)
The University Hospital in Krakow
Poland (PL)
Hospital Sírio-Libanês
Brazil (BR)
Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV)
Spain (ES)
Christie NHS Foundation Trust
United Kingdom (GB)
How to cite
APA:
Lamarca, A., Crona, J., Ronot, M., Opalinska, M., Lopez Lopez, C., Pezzutti, D.,... Dromain, C. (2018). Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The GREPONET Study. (pp. 178-178).
MLA:
Lamarca, A., et al. "Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The GREPONET Study." 2018. 178-178.
BibTeX: Download